What is ADVM stock price today?

Visit our real-time dashboard for the current ADVM stock price and live market data.

Is ADVM stock going up or down today?

ADVM stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ADVM stock now?

The decision to buy ADVM depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ADVM a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ADVM based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ADVM stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ADVM is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ADVM's P/E ratio?

P/E ratio data for ADVM will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ADVM's market cap?

ADVM (Adverum Biotechnologies Inc) has a market capitalization of $0.05 billion, making it a small-cap stock.

What is ADVM's price to book ratio?

Price-to-book ratio for ADVM is available on our dashboard along with other valuation metrics.

Does ADVM pay dividends?

ADVM does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ADVM's dividend yield?

ADVM does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ADVM stock a good long-term investment?

ADVM's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ADVM's revenue growth rate?

Revenue growth data for ADVM is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ADVM are available on our dashboard with complete income statement analysis.

What are the risks of investing in ADVM?

Key risks for ADVM include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ADVM compare to its competitors?

Compare ADVM to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ADVM's performance and positioning.

What is ADVM's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ADVM with bull, base, and bear case scenarios.

What do analysts say about ADVM?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ADVM. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ADVM's next earnings report?

ADVM reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ADVM - Adverum Biotechnologies Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Adverum Biotechnologies Inc

Adverum Biotechnologies Inc (ADVM) common stock

Price Chart

Loading chart...

ADVM Key Statistics

Market Cap

$47.63M

How ADVM Compares to Peers

ADVM is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 4

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
ADVM(This stock)	$47.63M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN

Data Updated: June 11, 2026 at 10:05 AM EDT

Ready to invest in ADVM?

Commission-free trading available. Affiliate links.

Upcoming Events for ADVM

Dashboard

Enter a ticker to analyze